Eventide Asset Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Sell |
200,000
-534
| -0.3% | -$28.5K | 0.19% | 124 |
|
|
2025
Q1 | $8.12M | Buy |
+200,534
| New | +$8.12M | 0.16% | 131 |
|
|
2023
Q4 | – | Sell |
-513,876
| Closed | -$26M | – | 153 |
|
|
2023
Q3 | $26M | Buy |
513,876
+134,756
| +36% | +$6.82M | 0.47% | 65 |
|
|
2023
Q2 | $17.7M | Hold |
379,120
| – | – | 0.3% | 91 |
|
|
2023
Q1 | $14.5M | Buy |
+379,120
| New | +$14.5M | 0.27% | 102 |
|